Organoids and tumours, surviving post chemotherapy, are highly enriched for L1CAM expression, and the combination of irinotecan and L1CAM knockdown is more potently cytotoxic than either treatment alone [166]. The gene discussed is L1CAM; the disease is neoplasm.